Stay updated on Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.

Latest updates to the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check12 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page history now shows a new UI text 'Find contact information' and updates to display the latest 'Revision: v3.7.0', replacing the older 'Find Contact Information' and 'Revision: v3.6.6' entries.SummaryDifference0.3%

- Check54 days agoChange DetectedThe record history now shows a new site revision v3.6.6 replacing the prior v3.6.5, indicating a software update to the page's history interface.SummaryDifference0.1%

- Check75 days agoChange DetectedThe study history now includes a new revision entry (v3.6.5), updating the record from the previous revision (v3.6.4).SummaryDifference0.1%

- Check89 days agoChange DetectedA new revision entry (v3.6.4) was added to the record history, replacing the previous revision (v3.6.3) to reflect an update in the record.SummaryDifference0.1%

Stay in the know with updates to Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.